Tumour recurrence in high-grade gliomas, such as glioblastoma, is extremely common due to the challenges associated with complete surgical removal. Approximately 95% of glioblastoma tumours recur within 2 cm of the tumour resection margin; however, unfortunately, the current clinical measurement techniques do not accurately capture cell state during critical stages of recurrence. The development of in vitro models for investig...